Clinicopathological relevance of BRAF and SMO mutations in Chinese patients with ameloblastoma

References

• Abu-Ghazaleh N, Chua WJ, Gopalan V. 2021. Intestinal microbiota and its association with colon cancer and red/processed meat consumption. J Gastroenterol Hepatol. 36(1):75–88. doi:10.1111/jgh.15042.
   PubMed Web of Science ®Google Scholar
• Bisogno LS, Keene JD. 2018. RNA regulons in cancer and inflammation. Curr Opin Genet Dev. 48:97–103. doi:10.1016/j.gde.2017.11.004.
   PubMed Web of Science ®Google Scholar
• Boffano P, Cavarra F, Tricarico G, Masu L, Brucoli M, Ruslin M, Forouzanfar T, Ridwan-Pramana A, Rodríguez-Santamarta T, Rui Ranz M, et al. 2021. The epidemiology and management of ameloblastomas: a European multicenter study. J Cranio-Maxillofacial Surg. 49(12):1107–1112. doi:10.1016/j.jcms.2021.09.007.
   PubMed Web of Science ®Google Scholar
• Bonacina R, Indini A, Massazza G, Rulli E, Gianatti A, Mandalà M, Ameloblastoma Cooperative Group. 2022. Correlation of BRAF mutational status with clinical characteristics and survival outcomes of patients with ameloblastoma: the experience of 11 Italian centres. J Clin Pathol. 75(8):555–559. doi:10.1136/jclinpath-2021-207527.
   PubMed Web of Science ®Google Scholar
• Brown NA, Rolland D, McHugh JB, Weigelin HC, Zhao L, Lim MS, Elenitoba-Johnson KSJ, Betz BL. 2014. Activating FGFR2–RAS–BRAF mutations in ameloblastoma. Clin Cancer Res. 20(21):5517–5526. doi:10.1158/1078-0432.CCR-14-1069.
   PubMed Web of Science ®Google Scholar
• Derakhshan S, Aminishakib P, Karimi A, Aminishakib P, Karimi A, Saffar H, Abdollahi A, Mohammadpour H, Fard MJK, Memarha A. 2020. High frequency of BRAF V600E mutation in Iranian population ameloblastomas. Med Oral Patología Oral y Cirugia Bucal. 25(4):e502–e507. doi:10.4317/medoral.23519.
   PubMed Web of Science ®Google Scholar
• Diniz MG, Gomes CC, Guimarães BV, Gomes CC, Guimarães BVA, Castro WH, Lacerda JCT, Cardoso SV, de Faria PR, Dias FL, et al. 2015. Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours. Tumor Biol. 36(7):5649–5653. doi:10.1007/s13277-015-3238-0.
   PubMedGoogle Scholar
• do Canto AM, da Silva Marcelino BMR, Schussel JL, Wastner BF, Sassi LM, Corrêa L, de Freitas RR, Hasséus B, Kjeller G, Junior CAL, et al. 2019. Immunohistochemical analysis of BRAF V600E mutation in ameloblastomas. Clin Oral Investig. 23(2):779–784. doi:10.1007/s00784-018-2494-y.
   PubMed Web of Science ®Google Scholar
• Doheny D, Manore SG, Wong GL, Lo H-W. 2020. Hedgehog signaling and truncated GLI1 in cancer. Cells. 9(9):2114. doi:10.3390/cells9092114.
   PubMed Web of Science ®Google Scholar
• Ghafouri-Fard S, Atarbashi-Moghadam S, Taheri M. 2021. Genetic factors in the pathogenesis of ameloblastoma, dentigerous cyst and odontogenic keratocyst. Gene. 771: 145369. doi:10.1016/j.gene.2020.145369.
   PubMed Web of Science ®Google Scholar
• Gomes DC, Jamra SA, Leal LF, Colli LM, Campanini ML, Oliveira RS, Martinelli Jr CE, Elias PCL, Moreira AC, Machado HR, et al. 2015. Sonic hedgehog pathway is upregulated in adamantinomatous craniopharyngiomas. Eur J Endocrinol. 172(5):603–608. doi:10.1530/EJE-14-0934.
   PubMed Web of Science ®Google Scholar
• Guimarães LM, Coura BP, Gomez RS, Gomes CC. 2021. The molecular pathology of odontogenic tumors: expanding the spectrum of MAPK pathway driven tumors. Frontiers Oral Health. 2:740788. doi:10.3389/froh.2021.740788.
   PubMedGoogle Scholar
• Gültekin SE, Aziz R, Heydt C, Sengüven B, Zöller J, Safi AF, Kreppel M, Buettner R. 2018. The landscape of genetic alterations in ameloblastomas relates to clinical features. Virchows Arch. 472(5):807–814. doi:10.1007/s00428-018-2305-5.
   PubMed Web of Science ®Google Scholar
• Heikinheimo K, Huhtala JM, Thiel A, Kurppa KJ, Heikinheimo H, Kovac M, Kragelund C, Warfvinge G, Dawson H, Elenius K, et al. 2019. The mutational profile of unicystic ameloblastoma. J Dent Res. 98(1):54–60. doi:10.1177/0022034518798810.
   PubMed Web of Science ®Google Scholar
• Hosoya A, Shalehin N, Takebe H, SHimo T, Irie K. 2020. Sonic hedgehog signaling and tooth development. Int J Mol Sci. 21(5):1587. doi:10.3390/ijms21051587.
   PubMed Web of Science ®Google Scholar
• Kim TE, Jung ES, Jung CK, Bae JS, Kim SN, Kim GS, Lee HN, Kang CS, Choi YJ. 2013. DHPLC is a highly sensitive and rapid screening method to detect BRAFV600E mutation in papillary thyroid carcinoma. Exp Mol Pathol. 94(1):203–209. doi:10.1016/j.yexmp.2012.05.011.
   PubMed Web of Science ®Google Scholar
• Kokubun K, Yamamoto K, Akashi Y, Chujo T, Nakajima K, Matsuzaka K. 2022. Genetic study of BRAF V600E and SMO L412F mutations in Japanese patients with ameloblastoma. Int J Surg Pathol. 30(4):378–384. doi:10.1177/10668969211064203.
   PubMed Web of Science ®Google Scholar
• Kunmongkolwut S, Chaisuparat R. 2022. Analysis of BRAF V600E expression and disease-free survival in patients with ameloblastoma. Int J Oral Maxillofac Surg. 51(8):1034–1042. doi:10.1016/j.ijom.2021.12.011.
   PubMed Web of Science ®Google Scholar
• Kurppa KJ, Catón J, Morgan PR, Ristimäki A, Ruhin B, Kellokoski J, Elenius K, Heikinheimo K. 2014. High frequency of BRAF V600E mutations in ameloblastoma. J Pathol. 232(5):492–498. doi:10.1002/path.4317.
   PubMed Web of Science ®Google Scholar
• Lee SK, Kim YS. 2013. Current concepts and occurrence of epithelial odontogenic tumors: I. ameloblastoma and adenomatoid odontogenic tumor. Korean J Pathol. 47(3):191–202. doi:10.4132/KoreanJPathol.2013.47.3.191.
   PubMedGoogle Scholar
• Malatesta M, Steinhauer C, Mohammad F, Pandey DP, Squatrito M, Helin K. 2013. Histone acetyltransferase PCAF is required for hedgehog-Gli-dependent transcription and cancer cell proliferation. Cancer Res. 73(20):6323–6333. doi:10.1158/0008-5472.CAN-12-4660.
   PubMed Web of Science ®Google Scholar
• Mota M, Shevde LA. 2020. Merlin regulates signaling events at the nexus of development and cancer. Cell Commun Signal. 18(1):63. doi:10.1186/s12964-020-00544-7.
   PubMed Web of Science ®Google Scholar
• Oh K-Y, Cho S-D, Yoon H-J, Lee JI, Ahn S-H, Hong S-D. 2019. High prevalence of BRAF V600E mutations in Korean patients with ameloblastoma: clinicopathological significance and correlation with epithelial-mesenchymal transition. J Oral Pathol Med. 48(5):413–420. doi:10.1111/jop.12851.
   PubMed Web of Science ®Google Scholar
• Owosho AA, Ladeji AM, Adebiyi KE, Olajide MA, Okoye ISI, Kehinde T, Nwizu NN, Summersgill KF. 2021. BRAF v600e mutation-specific immunohistochemical analysis in ameloblastomas: a 44-patient cohort study from a single institution. Eur Arch Oto-Rhino-Laryngol. 278(8):3065–3071. doi:10.1007/s00405-020-06491-w.
   PubMed Web of Science ®Google Scholar
• Petrovic ID, Migliacci J, Ganly I, Patel S, Xu B, Ghossein R, Huryn J, Shah J. 2018. Ameloblastomas of the mandible and maxilla. Ear Nose Throat J. 97(7):233–232. doi:10.1177/014556131809700704.
   PubMedGoogle Scholar
• Rui Z, Li-Ying P, Jia-Fei Q, Ying-Ying H, Feng C, Tie-Jun L. 2014. Smoothened gene alterations in keratocystic odontogenic tumors. Head Face Med. 10:36. doi:10.1186/1746-160X-10-36.
   PubMed Web of Science ®Google Scholar
• Shimura M, Nakashiro KI, Sawatani Y, Hasegawa T, Kamimura R, Izumi S, Komiyama Y, Fukumoto C, Yagisawa S, Yaguchi E, et al. 2020. Whole exome sequencing of SMO, BRAF, PTCH1 and GNAS in odontogenic diseases. In Vivo. 34(6):3233–3240. doi:10.21873/invivo.12159.
   PubMed Web of Science ®Google Scholar
• Shirsat PM, Bansal S, Prasad P, Desai RS. 2018. Low frequency of BRAF V600E immunoexpression in mandibular ameloblastomas: an institutional study. J Oral Maxillofac Pathol. 22(3):353–359. doi:10.4103/jomfp.JOMFP_174_17.
   PubMedGoogle Scholar
• Siar CH, Ishak I, Ng KH. 2015. Podoplanin, E-cadherin, β-catenin, and CD44v6 in recurrent ameloblastoma: their distribution patterns and relevance. J Oral Pathol Med. 44(1):51–58. doi:10.1111/jop.12203.
   PubMed Web of Science ®Google Scholar
• Soltani M, Tabatabaiefar MA, Mohsenifar Z, Pourreza MR, Moridnia A, Shariati L, Razavi SM. 2018. Genetic study of the BRAF gene reveals new variants and high frequency of the V600E mutation among Iranian ameloblastoma patients. J Oral Pathol Med. 47(1):86–90. doi:10.1111/jop.12610.
   PubMed Web of Science ®Google Scholar
• Soluk-Tekkesin M, Wright JM. 2022. The world health organization classification of odontogenic lesions: a summary of the changes of the 2022 (5th) edition. Turkish J Pathol. 38(2):168–184. doi:10.5146/tjpath.2022.01573.
   Web of Science ®Google Scholar
• Srivastava G, Padhiary SK, Nayak TK, Mishra N. 2022. Rehabilitation using implants in free fibula flap of a patient with ameloblastoma: case report with 4-year follow-up. Natl J Maxillofac Surg. 13(Suppl 1):s194–s198. doi:10.4103/njms.NJMS_239_20.
   PubMedGoogle Scholar
• Sweeney RT, McClary AC, Myers BR, Biscocho J, Neahring L, KAQu K, Gong K, Ng X, Jones T, D C, et al. 2014. Dentification of recurrent SMO and BRAF mutations in ameloblastomas. Nat Genet. 46(7):722–725. doi:10.1038/ng.2986.
   PubMed Web of Science ®Google Scholar
• Togni L, Zizzi A, Mazzucchelli R, Santarelli A, Rubini C, Mascitti M. 2022. Identification of BRAF V600E mutation in odontogenic tumors by high-performance MALDI-TOF analysis. Int J Oral Sci. 14(1):22. doi:10.1038/s41368-022-00170-8.
   PubMed Web of Science ®Google Scholar
• Wang C, Wu H, Katritch V, Han GW, Huang X-P, Liu W, Siu FY, Roth BL, Cherezov V, Stevens RC. 2013. Structure of the human smoothened receptor bound to an antitumour agent. Nature. 497(7449):338–343. doi:10.1038/nature12167.
   PubMed Web of Science ®Google Scholar
• Yoshimoto S, Morita H, Okamura K, Hiraki A, Hashimoto S. 2022. αTAT1-induced tubulin acetylation promotes ameloblastoma migration and invasion. Lab Invest. 102(1): 80–89. doi:10.1038/s41374-021-00671-w.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang J, Liu H, Zhang Y, Dong F. 2017. The clinicopathologic relevance of RECK gene polymorphisms in ameloblastoma. Arch Oral Biol. 79:77–86. doi:10.1016/j.archoralbio.2017.03.008.
   PubMed Web of Science ®Google Scholar